Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
by delcy
MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
Evidence Based Medicine In
Evidence Based Medicine In
by megan
Pharmacy Practice. Jarrod King, Pharm. D. . PGY1 U...
References (1) Epidemiology
References (1) Epidemiology
by jordyn
1. Queiroz LP, Peres MF, Piovesan EJ et al. . A na...
CETP inhibition : Where
CETP inhibition : Where
by rodriguez
are we . now. ?. Prof. John Kastelein. Academic. ...
European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4
European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4
by jasmine
ICH Topic E 10 Choice of Control Group in Clinical...
Tranexamic acid, civilian trauma and the CRASH-2 trial
Tranexamic acid, civilian trauma and the CRASH-2 trial
by sherrill-nordquist
Ian Roberts. Tranexamic acid and bleeding. The ...
Tranexamic acid, civilian trauma and the CRASH-2 trial
Tranexamic acid, civilian trauma and the CRASH-2 trial
by celsa-spraggs
Ian Roberts. Tranexamic acid and bleeding. The ...
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
by willow
Mary Kay Koenig, MD. Associate Vice Chair for Clin...
Phase II Clinical Trial Austin Goodrich and Laura Peterman
Phase II Clinical Trial Austin Goodrich and Laura Peterman
by della
Outline. Review of a phase I trial. What is a phas...
Recent U.S. Regulatory Efforts on Complex Innovative Clinical Trial Design
Recent U.S. Regulatory Efforts on Complex Innovative Clinical Trial Design
by bery
John Scott, Ph.D.. Director, Division of Biostatis...
Dupixent is indicated for the treatment of moderatetosevere atopic d
Dupixent is indicated for the treatment of moderatetosevere atopic d
by bella
First targeted biologic for adults with moderate-t...
FREEDOMS II TRIAL
FREEDOMS II TRIAL
by lois-ondreau
Study Design. 24-month, RCT of . fingolimod. 0.5...
Hypertension
Hypertension
by pamella-moone
What to do when you don’t know what to do!. Fio...
Scientific writing
Scientific writing
by karlyn-bohler
(81-933). Lecture 7: Abstract. Dr. Avraham Samso...
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
by sherrill-nordquist
Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...
When is a meta-analysis helpful?
When is a meta-analysis helpful?
by sherrill-nordquist
EBM: 9/18/2012. Evidence-based medicine. 25 year ...
The Use of Vitamin D in Clinical Practice
The Use of Vitamin D in Clinical Practice
by olivia-moreira
John J Cannell, MD. Executive Director, Vitamin D...
Dabigatran in myocardial injury after noncardiac
Dabigatran in myocardial injury after noncardiac
by lois-ondreau
surgery. Dr. PJ Devereaux on behalf of . MANAGE I...
Presenters for Journal Club:
Presenters for Journal Club:
by alida-meadow
James Cooper. Eugenie . Shieh. Aaron . Schueneman...
Update on Treatment of Myasthenia Gravis
Update on Treatment of Myasthenia Gravis
by conchita-marotz
KUMC Neurology Grand Rounds. 07/29/2016. Richard...
Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
Dr Krishnadas. N C​ Associate Professor Neurology, MES Medical College
Dr Krishnadas. N C​ Associate Professor Neurology, MES Medical College
by emma
​. DM Neurology (2011-2014) - Government Medical...
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
by thomas
Professor Salman Siddiqui, Clinical Professor of A...
New drugs, new hopes for systemic lupus erythematosus
New drugs, new hopes for systemic lupus erythematosus
by SocialButterfly
Dr. Konstantinos Tselios, MD, PhD. Assistant Profe...
Placebo Control Group The group of people in a drug trial who are not given the new
Placebo Control Group The group of people in a drug trial who are not given the new
by cecilia
drug. Open . trial . Both patient and the doct...
Reference based multiple imputation;
Reference based multiple imputation;
by liane-varnes
f. or sensitivity analysis of clinical trials wit...
Progress in the HIV Vaccine Field
Progress in the HIV Vaccine Field
by eatsui
Larry Corey, MD. Principal Investigator, NIAID sup...
Friedreich’s ataxia research update
Friedreich’s ataxia research update
by emery
Dr Julie Greenfield. Forward with Hope . Overview....
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
by OneAndOnly
VA Cooperative Studies Program Trial # 578. Contra...
Interprétation des essais cliniques pour la pratique médicale en oncologie
Interprétation des essais cliniques pour la pratique médicale en oncologie
by erica
Michel Cucherat. Lyon. Liens d’intérêt en onco...
Clinical Trials Oct . 6, Lyon France
Clinical Trials Oct . 6, Lyon France
by wayne461
Birthe Lemley. Executive. Board . Member. of ENG...
Copyright
Copyright
by mia
2021 Zacks Investment Research All Rights Reserved...
Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial
Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial
by relylancome
Robert J. Mentz, M. Angelyn Bethel, Peter Merrill,...
by billiontins
2018;36(8):773-9.. Nivolumab Monotherapy (Cohort 1...
by clustik
proceedings from the live CME event and may includ...
Management of Alcoholic Hepatitis
Management of Alcoholic Hepatitis
by friendma
and Cirrhosis. W. Ray Kim, MD. Gastroenterology an...
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
by tawny-fly
Post-Menopausal Women with Hormone-Receptor Posit...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...